These recalls involve products that pose serious risks of injury or death. Check if you own any of these products and take immediate action if needed.

High Risk Recalls

630 critical product recalls that require immediate attention. These products have been identified as posing serious safety hazards.

What to do if you own a recalled product:

  1. Stop using the product immediately
  2. Keep the product away from children
  3. Follow the remedy instructions provided
  4. Contact the manufacturer for a refund or replacement
Recalled Nimbus Lock Carabiners
HIGH
CPSC

C.A.M.P. Recalls Nimbus Lock Carabiners Due to Fall Risk

C.A.M.P. recalled Nimbus Lock Carabiners on August 28, 2025, after discovering a defect that can prevent the gate from closing. This poses a significant risk of serious injury or death from falls. The recall affects carabiners sold in multiple colors and batch numbers between October 2023 and June 2025.

Nimbus
The carabiner's
Read more
Recalled CT-ENERGY Lithium Coin Battery Charger with Rechargeable 2032 Batteries
HIGH
CPSC

CT-ENERGY Battery Chargers Recalled Over Serious Injury Risk

CT-ENERGY recalled Lithium Coin Battery Chargers on August 28, 2025. The chargers can expose children to easily accessible lithium batteries, posing a risk of serious injury or death from ingestion. Consumers should stop using the product immediately and seek refunds.

CT-ENERGY
The recalled
Read more
HIGHFDA DRUG

Granules Pharmaceuticals Recalls Dextroamphetamine Capsules for Impurities

Granules Pharmaceuticals Inc. recalled 11,895 bottles of extended-release capsules on August 28, 2025. The capsules failed impurities and degradation specifications. Consumers should stop using the product immediately, as it could pose health risks.

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Failed Impurities/Degradation
Read more
HIGHFDA DRUG

Granules Pharmaceuticals Recalls Amphetamine Capsules for Degradation Issues

Granules Pharmaceuticals Inc. recalled 3,384 bottles of amphetamine capsules on August 28, 2025. The recall follows a failure to meet impurities and degradation specifications. Consumers should stop using this product immediately and consult healthcare providers.

Granules Pharmaceuticals Inc.
Failed Impurities/Degradation
Read more
HIGHFDA DRUG

Granules Pharmaceuticals Recalls Dextroamphetamine Capsules Over Contamination Risk

Granules Pharmaceuticals Inc. recalled 9,917 bottles of Dextroamphetamine extended-release capsules on August 28, 2025. The product failed impurities and degradation specifications, posing potential health risks. Consumers should stop using the capsules immediately and consult healthcare providers for guidance.

Granules Pharmaceuticals
Failed Impurities/Degradation
Read more
HIGHFDA DRUG

Granules Pharmaceuticals Recalls Amphetamine Capsules Over Impurity Risks

Granules Pharmaceuticals recalled 11,928 bottles of amphetamine capsules on August 28, 2025. The recall follows failure to meet impurities and degradation specifications. Consumers should stop using the product immediately and contact their healthcare providers.

Granules Pharmaceuticals
Failed Impurities/Degradation
Read more
HIGHFDA DRUG

Ascend Laboratories Recalls Aripiprazole Tablets Due to Potency Risk

Ascend Laboratories, LLC recalled 2,256 bottles of Aripiprazole Tablets on August 28, 2025. The recall followed reports that the drug may be superpotent, posing serious health risks. Consumers should stop using the product immediately and consult healthcare providers.

ARIPIPRAZOLE
Superpotent drug
Read more
HIGHFDA DRUG

Granules Pharmaceuticals Recalls Dextroamphetamine Capsules Over Impurity Concerns

Granules Pharmaceuticals Inc. recalled 11,909 bottles of Dextroamphetamine extended-release capsules on August 28, 2025. The recall stems from failure to meet impurities and degradation specifications. Healthcare providers and consumers must stop using the product immediately.

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Failed Impurities/Degradation
Read more
HIGHFDA DEVICE

Siemens Medical MRI Machines Recalled Over Helium Leak Risk

Siemens Medical Solutions USA recalled 18 MAGNETOM Skyra Fit BioMatrix MRI machines on August 28, 2025. The recall addresses a potential ice blockage in the magnet venting system, which could lead to helium gas leaks. Users must stop using the devices immediately and follow recall instructions.

Siemens Medical Solutions USA
There is
Read more
HIGHFDA DEVICE

Siemens MRI Scanner Recalled Due to Helium Leak Risk

Siemens Medical Solutions USA recalled 237 MAGNETOM Vida MRI scanners on August 28, 2025. The recall stems from a potential ice blockage in the magnet venting system which may cause helium leaks. The affected model number is 11060815, distributed worldwide, including the U.S.

Siemens Medical Solutions USA
There is
Read more
HIGHFDA DEVICE

Siemens Medical MRI System Recalled Due to Helium Leak Risk

Siemens Medical Solutions USA recalled 30 units of the MAGNETOM Skyra fit MRI system on August 28, 2025. The recall addresses a potential ice blockage in the magnet venting system that could lead to a helium leak. The device is distributed worldwide, including the US and multiple countries.

Siemens Medical Solutions USA
There is
Read more
HIGHFDA DEVICE

Siemens MRI Scanner Recalled Due to Helium Leak Risk

Siemens Medical Solutions USA recalled 39 MAGNETOM Prisma MRI scanners on August 28, 2025, due to a potential helium leak hazard. The recall affects units distributed worldwide, with a significant risk of helium gas build-up within the containment system. Healthcare providers must stop using the device immediately and follow recall instructions.

Siemens Medical Solutions USA
There is
Read more
HIGHFDA DEVICE

Siemens MRI System Recalled Over Potential Helium Leak Risk

Siemens Medical Solutions USA recalled 30 MRI systems on August 28, 2025 due to a risk of helium leaks. The recall affects the MAGNETOM Verio Dot model number 10684333. The potential ice blockage in the venting system could lead to a pressure build-up and rupture.

Siemens Medical Solutions USA
There is
Read more
HIGHFDA DEVICE

Siemens Recalls Biograph mMR Due to High Pressure Risk

Siemens Medical Solutions USA recalled 23 units of the Biograph mMR on August 28, 2025, due to a potential helium leak risk. The recall affects devices distributed worldwide, including the US. This Class I recall poses a high hazard to patients and healthcare providers.

Siemens Medical Solutions USA
There is
Read more
HIGHFDA DEVICE

Siemens MRI Device Recalled Due to Helium Leak Risk

Siemens Medical Solutions USA recalled 27 units of its MAGNETOM Vida Fit MRI system on August 28, 2025. The recall addresses a risk of ice blockage that can cause helium gas pressure build-up. This defect may lead to a helium leak in the scanning room, posing a safety hazard.

Siemens Medical Solutions USA
There is
Read more
HIGHFDA DEVICE

Siemens MRI Scanner Recalled Due to High Pressure Risk

Siemens Medical Solutions USA recalled nine MRI scanners on August 28, 2025. The devices may develop ice blockages in the venting system, risking helium leaks. Healthcare providers must stop using the scanners immediately.

Siemens Medical Solutions USA
There is
Read more
HIGHFDA DEVICE

Siemens Medical MRI Scanner Recalled Due to Helium Leak Risk

Siemens Medical Solutions USA recalled the MAGNETOM Connectom.X. MRI Scanner on August 28, 2025. The recall affects one unit worldwide due to a potential helium leak risk. Users must stop using the device immediately as it poses a high hazard level.

Siemens Medical Solutions USA
There is
Read more
HIGHFDA DEVICE

Siemens Medical Recalls MRI Machine Over Helium Leak Risk

Siemens Medical Solutions USA recalled 182 MRI machines on August 28, 2025, due to a risk of helium leaks. An ice blockage in the magnet venting system could cause pressure build-up, leading to a potential rupture. Users must stop using the device and follow recall instructions immediately.

Siemens Medical Solutions USA
There is
Read more
Advertisement